Home BioStable Science & Engineering

BioStable Science & Engineering

BioStable Science & Engineering Announces U.S. Pilot Launch and First Commercial Use of the HAART™ 300 Aortic Annuloplasty Device

BioStable Science & Engineering, Inc. announced today the first commercial uses of the HAART 300 Aortic Annuloplasty...

BioStable Science & Engineering Announces FDA Clearance of the HAART™ 300 Aortic Annuloplasty Device

BioStable Science & Engineering, Inc. announced today it has received FDA market clearance for the HAART 300...